Asensus Surgical (NYSE:ASXC) announced today that it entered into an agreement to lease a Senhance surgical robot to a Japanese hospital.
Kashiwa Kosei General Hospital (Kashiwa, Japan) agreed to lease the surgical robot system. It marks the second recent adoption of Senhance in Japan. In September, Saiseikai Shiga Hospital in Ritto, Japan, agreed to lease a surgical robot.
“We are pleased to be partnering with another impressive institution as we continue to see high adoption rates in one of the fastest growing regions for Asensus,” said Anthony Fernando, Asensus Surgical president and CEO. “The recently approved thoracic indication will be a great addition to the Kashiwa Kosei General Hospital’s surgery department.”
Senhance, a first-of-its-kind digital laparoscopic surgical robot, uses augmented intelligence to perform procedures through machine learning. It features surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization.
It’s the first platform to offer 3mm instruments. They represent the smallest instrument available in the world on a robotic surgical platform, Asensus says.
Senhance enables machine vision-driven control of its camera for a surgeon by responding to commands and recognizing objects and locations. It allows the surgeon to change the visualized field of view using the movement of their instruments.
“We are excited to bring the Senhance Surgical System into our existing surgical robotics department,” said Dr.Takashi Suwa, director and gastrointestinal surgeon at Kashiwa Kosei General Hospital. “We aim to provide the latest advancements in medical care to fulfill our responsibilities as a regional hospital.”